acyclovir

Product NDC
70436-030
11-digit product format
704360030
Labeler code
70436
Product ID
70436-030_1280dbca-a2d7-49cf-e063-6394a90a7596
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acyclovir
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Slate Run Pharmaceuticals, LLC
Application
ANDA218111
Marketing category
ANDA
Marketing start
2024-03-01
Substance
ACYCLOVIR SODIUM
Active strength
50 mg/mL
Pharmacologic classes
DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218111-001ACYCLOVIR SODIUMACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A218111-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-0831067a03dcf5…
2025-08-23 18:47 UTC2025-08A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-086a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-0803ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-082680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-085bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-0879d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-081e350fbaab3a…
2024-05-31 18:47 UTC2024-05A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-088072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-086a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-081c564ffb4f44…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218111-001ACYCLOVIR SODIUMEQ 50MG BASE/MLINJECTABLE / INJECTIONAP2024-01-08a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-18 06:07:402026-07A218111-001AP1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A218111-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218111-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A218111-001AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A218111-001AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A218111-001AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A218111-001AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A218111-001AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A218111-001AP15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A218111-001AP1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A218111-001AP1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A218111-001AP179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A218111-001AP1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A218111-001AP11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A218111-001AP18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A218111-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A218111-001AP11c564ffb4f44…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218111-001AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
acyclovir
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ACYCLOVIR SODIUM50 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
927L42J563Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1734932Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
889bccd1-3793-40ce-bca2-c8c9cf6b7488Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
33190c02-82e1-0a4d-d716-9ccd23588463Product name520250225
c367d1da-5a72-8966-6d11-1eb9a73ae758Product name320231115
5518bf13-db2f-2e9c-3679-e70ecf03752cProduct name920210614
27897900-0e40-497b-97e1-88057e68fe6cProduct name420200710
ca834e59-e669-229c-9288-0ccb76dc373eProduct name920200220
d7f95c49-d3e1-4bbc-a389-e9cd73f59a28Product name120190702
fb15b394-3715-4c87-a447-421489aa8739Product name320170727
7bdc4804-3832-c0df-e519-72b6d47c9792Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70436-030-82acyclovir10 in 1 CARTONINJECTION, SOLUTION102
70436-030-82acyclovir10 mL in 1 VIAL, SINGLE-DOSEINJECTION, SOLUTION102

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70436-030-82ML - Milliliter70436-030d231fbda-5cf0-4e25-be72-0f2abdb7b81e12024-08-12

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70436-030ACYCLOVIR INJECTION, SOLUTION [SLATE RUN PHARMACEUTICALS, LLC]2Current NDC, 2 package rows20240302_889bccd1-3793-40ce-bca2-c8c9cf6b7488.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
acyclovirACYCLOVIRSlate Run Pharmaceuticals, LLC889bccd1-3793-40ce-bca2-c8c9cf6b74882024-02-29Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218111
application number: ANDA218111
ndc (product): 70436-030

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1734932acyclovir sodium 500 MG in 10 ML InjectionPSN889bccd1-3793-40ce-bca2-c8c9cf6b74882
173493210 ML acyclovir 50 MG/ML InjectionSCD889bccd1-3793-40ce-bca2-c8c9cf6b74882
173493210 ML acycycloguanosine 50 MG/ML InjectionSY889bccd1-3793-40ce-bca2-c8c9cf6b74882
1734932acyclovir 50 MG/ML (equivalent to acyclovir sodium 54.9 MG/ML) per 10 ML InjectionSY889bccd1-3793-40ce-bca2-c8c9cf6b74882
1734932acyclovir 500 MG per 10 ML InjectionSY889bccd1-3793-40ce-bca2-c8c9cf6b74882

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70436-030-827043600308210 VIAL, SINGLE-DOSE in 1 CARTON (70436-030-82) / 10 mL in 1 VIAL, SINGLE-DOSE2024-03-01NoNoCurrent